Aptose Biosciences Inc. (APTO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	8-K	10-K	10-K	10-K	10-K	10-K	20-F	20-F
Revenues [+]	0.0	0.0	0.0	0.0	0.0	0.0	10.3	6.3
Royalties							10.3	6.3
Revenue growth						-100.0%	65.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	10.3	6.3
Gross margin							100.0%	100.0%
Selling, general and administrative [+]	14.5	19.5	26.5	10.0	10.4	5.6	8.3	9.8
General and administrative	14.5	19.5	26.5	10.0	10.4	5.6	8.3	9.8
Research and development	28.1	46.0	29.3	16.8	18.7	6.3
Other operating expenses		0.0	0.0	0.0	0.1	-0.2	10.3	6.3
EBITDA [+]		-65.3	-55.6	-26.7	-29.1	-11.5	-8.2	-9.7
EBITDA growth	-34.8%	17.4%	108.3%	-8.3%	152.8%	40.6%	-16.0%
EBITDA margin							-79.3%	-155.9%
Depreciation and amortization		0.2	0.2	0.2	0.1	0.1	0.2	0.1
EBIT [+]	-42.6	-65.4	-55.8	-26.8	-29.2	-11.6	-8.3	-9.8
EBIT growth	-34.9%	17.4%	107.7%	-8.0%	151.8%	39.0%	-15.2%
EBIT margin							-80.8%	-157.4%
Interest income		0.1	0.5	0.6	0.3	0.1
Interest income		0.1	0.5	0.6	0.3	0.1
Other income (expense), net [+]	0.8	0.0	0.0	0.0	0.0	-0.1	8.3	9.8
Gain (loss) on foreign currency transactions		0.0	0.0	0.0	0.0	0.1
Pre-tax income	-41.8	-65.4	-55.2	-26.3	-28.9	-11.6	0.0	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-41.8	-65.4	-55.2	-26.3	-28.9	-11.6	0.0	0.0
Net margin							0.0%	0.0%

Basic EPS [+]	($0.45)	($0.73)	($0.67)	($0.52)	($0.86)	($0.52)
Growth	-38.7%	8.7%	28.8%	-39.4%	65.7%
Diluted EPS [+]	($0.45)	($0.73)	($0.67)	($0.52)	($0.86)	($0.52)
Growth	-38.7%	8.7%	28.8%	-39.4%	65.7%

Shares outstanding (basic) [+]	92.9	89.1	81.8	50.2	33.4	22.3
Growth	4.3%	8.9%	63.2%	50.2%	49.6%
Shares outstanding (diluted) [+]	92.9	89.1	81.8	50.2	33.4	22.3
Growth	4.3%	8.9%	63.2%	50.2%	49.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.